Journal Information
Vol. 5. Issue 1.
Pages 2-5 (January - March 2012)
Share
Share
Download PDF
More article options
Visits
...
Vol. 5. Issue 1.
Pages 2-5 (January - March 2012)
CASE REPORT
DOI: 10.1016/j.optom.2012.02.003
Open Access
Non‐contact meibography in diagnosis and treatment of non‐obvious meibomian gland dysfunction
Meibografía sin contacto en el diagnóstico y tratamiento de la disfunción de las glándulas de Meibomio no obvia
Visits
...
Heiko Pulta,b,c,??
Corresponding author
ovr@heiko-pult.de

Corresponding author. H Pult, Optometry and Vision Research, Steingasse 15, Weinheim 69469, Germany.
, Britta H. Riede‐Pulta,b
a Optometry and Vision Research, Weinheim, Germany
b School of Optometry & Vision Sciences, Cardiff University, UK
c Contact Lens & Anterior Eye Research (CLAER) Unit, School of Optometry & Vision Sciences, Cardiff University, UK
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (3)
Show moreShow less
Tables (1)
Table 1. Area of loss of the upper and lower lids before and after treatment.
Abstract

Meibomian gland dysfunction (MGD) is the most common cause of dry eye and is recommended to be treated by warm and moist compresses followed by lid massage and lid scrub. This case report describes changes of ocular sign, tear film and meibomian gland morphology of a non‐obvious MGD patient (lid margin, meibomian gland orifices and ocular signs appeared to be normal) undergoing MGD treatment. Without gland expression and/or meibography this form of MGD would have been overseen. Tear film, ocular signs and symptoms improved significantly after treatment. Expressibility of glands was improved with treatment although the MGD accompanying loss of meibomian glands —evaluated by non‐contact meibography— was unchanged. Loss of meibomian glands might either be irreversible or would need more extended treatment.

Keywords:
Meibomian gland dysfunction
Dry eye
Meibography
Treatment Lid hygiene
Lid warming
Tearfilm
Resumen

La disfunción de las glándulas de Meibomio (DGM) es la causa más frecuente de ojo seco y se recomienda tratarla con compresas tibias y húmedas y a continuación un masaje y fregado de párpados. En este caso clínico se describen los cambios de signos oculares, de la película lagrimal y la morfología de las glándulas de Meibomio de un paciente con DGM no obvia (el margen del párpado, los orificios de las glándulas de Meibomio y los signos oculares parecían normales) sometido a tratamiento para la DGM. Sin la expresión de las glándulas y/o la meibografía, esta forma de DGM se habría examinado. La película lagrimal y los signos y síntomas oculares mejoraron de manera significativa tras el tratamiento. La expresividad de las glándulas mejoró con el tratamiento, aunque la DGM que iba unida a la pérdida de glándulas de Meibomio ??evaluadas mediante meibografía sin contacto?? permaneció sin cambios. La pérdida de glándulas de Meibomio puede ser irreversible o requerir un tratamiento más extenso.

Full Text
Introduction

Meibomian gland dysfunction (MGD) is one of the most common abnormalities in ophthalmic practice1 causing an abnormality of the tear film lipid layer2 resulting in the evaporative dry eye.3 MGD can be diagnosed by lid morphology, MG mass, gland expressibility, lipid layer thickness and loss of MG by meibography.3 Meibography is a technique to visualize the morphology of the meibomian glands. One principal is the transillumination of the everted lid4–6 the other one the direct illumination, named the non‐contact meibography.7–10 In transillumination the lid is everted over a light source5,11 while non‐contact meibography10 consist of a slit lamp equipped with an infrared charge‐coupled device video camera and an infrared transmitting filter10 to allow the observation of the everted lid without contact to the instrument. Recently our group described using a normal IR CCD camera in meibography instead12,13 or the built‐in IR cameras of common ophthalmic instruments to be designed for pupillometry (Figure 1).12,14,15 Later on this idea was used by Srinivasan et al.14,16

Figure 1.

An example of normal meibomian glands morphology. Photograph was taken by a modified Sirius® Scheimpflug Camera using the pupillometry option (C.S.O, Construzionne Strumenti Oftalmici, Florence, Italy; bon Optic VertriebsgmbH, Lübeck, Germany).12,15.

(0.12MB).

Blackie et al17 were first describing the “non‐obvious MGD”. A form of MGD where inflammation and ocular signs of pathology may be minimal and thus non‐obvious or absent altogether.17 This form of MGD would only be detectable by evaluating the expressibility of glands and extend of gland drop‐out.17 Additionally to gland expression meibography give the practitioner further information of the subjects meibomian gland morphology and long‐term effect of MGD.10,11

Loss of meibomian glands analyzed by meibograpy is significantly correlated to dry eye symptoms and tear film.13 Daily application of warm and moist compresses, followed by appropriate lid hygiene improves MGD.18,19 While tear film, ocular signs, symptoms and expressibility of glands can improve applying this treatement19,20 its unknown the effect on in the meibomian glands loss criteria.

Case report

A 42 year old white female claimed dry eye. Symptoms were assessed by the Ocular Surface Disease Index (OSDI). OSDI score was 37.5. Lid margin and meibomian gland orifices appeared to be normal (Figure 2), no meibomian gland plugging, no conjunctival or corneal staining or redness (Efron Grading Scale21: Grade <1), however meibomian glands were poorly expressible and expressed fluid was turbid. Loss of meibomian glands was evaluated by the portable non‐contact infra‐red (IR) meibograph (PNCM)13 and computerized grading (ImageJ 1.42q, Wayne Rasband, National Institute of Health, USA)13 and resulted in 37% (OD) loss of glands of the upper lid (Table 1). Non‐invasive break‐up time (NIBUT) was measured with the Tearscope® (Keeler, UK Ltd.) with a fine grid insert. The median of three consecutive measurements was 7.1 seconds (OD).22 Lipid layer thickness was less than 30 nm23 evaluated using the Tearcsope (without grid). Schirmer test I was 16 mm (OD).

Figure 2.

The lower lid and upper of the right eye observed before treatment.

(0.21MB).
Table 1.

Area of loss of the upper and lower lids before and after treatment.

  Upper lidLower lid
  (OD)  (OS)  (OD)  (OS) 
Before treatment  37%  42%  45%  51% 
After treatment  40%  39%  48%  45% 

Hyper‐evaporative dry eye caused by MGD was diagnosed because of OSDI scores,24,25 the poor expressibility of the glands,17,25 the reduced tear film stability25 and lipid layer thickness25 and meibomian gland loss of more than 30%7,8,13,25 but normal Schirmer test. Since lids appeared to be normal (no obvious inflammation and other signs of pathology17) MGD was classified as “non‐obvious MGD”.17

The response to treatment was evaluated by expressibility, character of secretion and loss of glands determined by meibography.17,20 Daily use of Blephasteam® eye lid warming device (Thea Laboratoires, Clermont‐Ferrand, France) followed by lid massage and lid scrub using Blepha Cura® (Optima Pharmazeutische GmbH, Moosburg/Wang, Germany) was recommended.

At the follow‐up after 3 weeks, expressibility of the meibomian glands was normal and the expressed meibom oil was clear and fluid. NIBUT improved to 11.2 seconds (OD), OSDI scores decreased significantly to 2.8. Lipid layer thickness was 75 nm. Schirmer test (17 mm) and loss of meibomian glands (OD, 40%) (Figure 3, Table 1) was unchanged.

Figure 3.

Loss of meibomian glands before (right) and after 3 weeks treatment (left). Meibographs were taken by the portable non‐contact IR meibograph (PNCM).13.

(0.21MB).
Conclusions

The daily use of the eyelid warming device —followed by lid massage and lid scrub— over a 3 week period significantly improved the patient‘s dry eye symptoms, as well as tear film stability and meibomian gland dysfunction (MGD) scores. The lipid layer thickness increased significantly even though 75 nm thickness is still borderline.23 The tear film stability measured by the tearscope approached normal values.26 However loss of meibomian glands was unchanged (Figure 3).

These findings are of interests, since MGD might have been overseen without expression of the glands and/or meibography. Expression and the evaluation of gland loss is essential in evaluating MGD, especially in the non‐obvious form.17 Meibography images let us assume a long history of MGD10 of this 42 year old patient. Lid hygiene as described is able to improve function of the remaining meibomian glands to improve tear film stability and function in relief of symptoms of dry eye. Furthermore these findings let us assume that loss of meibombian glands might be irreversible or would need longer and advanced treatment. However, MGD treatment by lid warming, lid massage and lid scrub was effective and might reduce or stop progression of the meibomian glands degeneration even in early MGD status.

Longitudinal investigation is ongoing to confirm this hypothesis in an appropriate sample size.

References
[1]
G.N. Foulks, A.J. Bron.
Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading.
Ocul Surf, 1 (2003), pp. 107-126
[2]
E. Knop, et al.
Meibomian glands: part III. Dysfunction ‐ argument for a discrete disease entity and as an important cause of dry eye.
Ophthalmologe, 106 (2009), pp. 966-979
[3]
K.K. Nichols, et al.
The International Workshop on Meibomian Gland Dysfunction: Executive Summary.
Invest Ophthalmol Vis Sci, 52 (2011), pp. 1922-1929
[4]
W.D. Mathers, T. Daley, R. Verdick.
Video imaging of the meibomian gland.
Arch Ophthalmol, 112 (1994), pp. 448-449
[5]
N. Yokoi, A. Komuro, H. Yamada, K. Maruyama, S. Kinoshita.
A newly developed video‐meibography system featuring a newly designed probe.
Jpn J Ophthalmol, 51 (2007), pp. 53-56
[6]
J.J. Nichols, D.A. Berntsen, G.L. Mitchell, K.K. Nichols.
An assessment of grading scales for meibography images.
Cornea, 24 (2005), pp. 382-388
[7]
R. Arita, et al.
Proposed diagnostic criteria for seborrheic meibomian gland dysfunction.
[8]
R. Arita, et al.
Efficacy of Diagnostic Criteria for the Differential Diagnosis Between Obstructive Meibomian Gland Dysfunction and Aqueous Deficiency Dry Eye.
Jpn J Ophthalmol, 54 (2010), pp. 387-391
[9]
R. Arita, et al.
Contact Lens Wear Is Associated with Decrease of Meibomian Glands.
Ophthalmology, 116 (2009), pp. 379-384
[10]
R. Arita, K. Itoh, K. Inoue, S. Amano.
Noncontact infrared meibography to document age‐related changes of the meibomian glands in a normal population.
Ophthalmology, 115 (2008), pp. 911-915
[11]
L.C. McCann, A. Tomlinson, E.I. Pearce, C. Diaper.
Tear and meibomian gland function in blepharitis and normals.
Eye Contact Lens, 35 (2009), pp. 203-208
[12]
H. Pult, B. Riede-Pult.
Neues zur Meibographie.
Die Kontaktlinse, 6 (2011), pp. 24-25
[13]
Pult H, Riede‐Pult BH. Non‐contact meibography: Keep it simple but effective. Contact Lens and Anterior Eye. 2011 [In Press, Corrected Proof].
[14]
S. Srinivasan, L. Sorbara, L.W. Jones, W. Sickenberger.
Imaging the Structure of the Meibomian Glands.
Contact Lens Spectrum, 7 (2011), pp. 52-53
[15]
H. Pult, B. Riede-Pult.
Die Meibomschen Drüsen.
In Optometrie 11; Berlin, (2011),
[16]
Srinivasan S, Menzies K, Sorbara L, Jones L. Imaging meibomian gland structures using the OCULUS Keratograph. in American Academy of Optometry conference. Boston, USA; 2011.
[17]
C.A. Blackie, et al.
Nonobvious Obstructive Meibomian Gland Dysfunction.
Cornea, 29 (2010), pp. 1333-1345
[18]
A. Spiteri, et al.
Tear lipid layer thickness and ocular comfort with a novel device in dry eye patients with and without Sjogren‘s syndrome.
J Fr Ophtalmol, 30 (2007), pp. 357-364
[19]
G. Geerling, et al.
The International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on Management and Treatment of Meibomian Gland Dysfunction.
Invest Ophthalmol Vis Sci, 52 (2011), pp. 2050-2064
[20]
D.R. Korb, C.A. Blackie.
Restoration of Meibomian Gland Functionality With Novel Thermodynamic Treatment Device‐A Case Report.
[21]
N. Efron.
Grading scales for contact lens complications.
Ophthalmic Physiol Opt, 18 (1998), pp. 182-186
[22]
L.S. Mengher, A.J. Bron, S.R. Tonge, D.J. Gilbert.
A non‐invasive instrument for clinical assessment of the pre‐corneal tear film stability.
Curr Eye Res, 4 (1985), pp. 1-7
[23]
D.R. Korb, et al.
Tear film lipid layer thickness as a function of blinking.
Cornea, 13 (1994), pp. 354-359
[24]
R.M. Schiffman, M.D. Christianson, G. Jacobsen, J.D. Hirsch, B.L. Reis.
Reliability and validity of the Ocular Surface Disease Index.
Arch Ophthalmol, 118 (2000), pp. 615-621
[25]
A. Tomlinson, et al.
The International Workshop on Meibomian Gland Dysfunction: Report of the Diagnosis Subcommittee.
Invest Ophthalmol Vis Sci, 52 (2011), pp. 2006-2049
[26]
L.S. Mengher, K.S. Pandher, A.J. Bron.
Non‐invasive tear film break‐up time: sensitivity and specificity.
Acta Ophthalmol (Copenh), 64 (1986), pp. 441-444
Journal of Optometry

Subscribe to our newsletter

Article options
Tools

Are you a health professional able to prescribe or dispense drugs?